Finch Therapeutics Group (NASDAQ: FNCH)
$2.31
(-0.4%)
-$0.01
Price as of April 29, 2024, 1:40 p.m. ET
Finch Therapeutics Group Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Finch Therapeutics Group Company Info
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Somerville, MA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.